PROCEPT BioRobotics (PRCT) Cash from Operations Growth (3y) (2023 - 2026)
PROCEPT BioRobotics (PRCT) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 0.50% |
| 10 | PROCEPT BioRobotics | 1.00 Bn | 758.56 Mn | 53.95 Mn | -2.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00% |
| Dec 31, 2025 | 25.70% |
| Sep 30, 2025 | 30.60% |
| Jun 30, 2025 | 4.23% |
| Mar 31, 2025 | 2.34% |
| Dec 31, 2024 | -25.27% |
| Sep 30, 2024 | -13.82% |
| Jun 30, 2024 | -6.82% |
| Mar 31, 2024 | -28.55% |
| Dec 31, 2023 | -22.63% |